EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieStudienprotokollOpen Access

Increasing the adoption of evidence-based communication practices for HPV vaccination in primary care clinics: The HPV ECHO study protocol for a cluster randomized controlled trial

William A Calo, Parth D Shah, Benjamin N Fogel, Mack T Ruffin Iv, Jennifer L Moss, Bernice L Hausman, Joel E Segel, Erica Francis, Eric Schaefer, Chelsea M Bufalini, Nikole Johnston, Ellie Hogentogler und 1 weitere

Contemporary Clinical Trials · 2023

DOI: 10.1016/j.cct.2023.107266 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Contemporary Clinical Trials, 2023. Verfasst von William A Calo und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Public Health Sciences, Penn State College of Medicine, Hershey, PA, USA; Penn State Cancer Institute, Hershey, PA, USA. Electronic add…. Hauptthemen laut MEDLINE: Papillomavirus Infections, Papillomavirus Vaccines. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NCATS NIH HHS, National Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: The safe, highly-effective human papillomavirus (HPV) vaccine remains underused in the US. The Announcement Approach Training (AAT) has been shown to effectively increase HPV vaccine uptake by training providers to make strong vaccine recommendations and answer parents' common questions. Systems communications, like recall notices, can further improve HPV vaccination by reducing missed clinical opportunities for vaccination. Never tested in supporting HPV vaccination, the ECHO (Extension for Community Healthcare Outcomes) model is a proven implementation strategy to increase best practices among healthcare providers. This trial uses a hybrid effectiveness-implementation design (type II) to evaluate two ECHO-delivered interventions intended to increase HPV vaccination rates. METHODS: This 3-arm cluster randomized controlled trial will be conducted in 36 primary care clinics in Pennsylvania.

Aim

1 evaluates the impact of HPV ECHO (AAT to providers) and HPV ECHO+ (AAT to providers plus recall notices to vaccine-declining parents) versus control on HPV vaccination (≥1 dose) among adolescents, ages 11-14, between baseline and 12-month follow-up (primary outcome). Using a convergent mixed-methods approach, Aim 2 evaluates the implementation of the HPV ECHO and HPV ECHO+ interventions.

Aim

3 explores exposure to and impact of vaccine information from providers and other sources (e.g., social media) on secondary acceptance among 200 HPV vaccine-declining parents within 12 months. DISCUSSION: We expect to demonstrate the effectiveness and evaluate the implementation of two highly scalable interventions to increase HPV vaccination in primary care clinics. Our study seeks to address the communication needs of both providers and parents, increase HPV vaccination, and, eventually, prevent HPV-related cancers. TRIAL REGISTRATION: ClinicalTrials.govNCT04587167. Registered on October 14, 2020.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Papillomavirus InfectionsPapillomavirus VaccinesAdolescentHumansVaccinationCommunicationParentsPrimary Health CareRandomized Controlled Trials as Topic

Stichwörter der Autor:innen

Healthcare providersHuman papillomavirus vaccineImplementation outcomesPrimary care clinicsVaccine communicationVaccine hesitancy

Substanzen

Papillomavirus Vaccines

Autor:innen und Institutionen

  • Department of Public Health Sciences, Penn State College of Medicine, Hershey, PA, USA; Penn State Cancer Institute, Hershey, PA, USA. Electronic address: wcalo@pennstatehealth.psu.edu.
  • Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Department of Pediatrics, Penn State College of Medicine, Hershey, PA, USA.
  • Department of Family and Community Medicine, Penn State College of Medicine, Hershey, PA, USA.
  • Department of Public Health Sciences, Penn State College of Medicine, Hershey, PA, USA; Penn State Cancer Institute, Hershey, PA, USA; Department of Family and Community Medicine, Penn State College of Medicine, Hershey…
  • Department of Public Health Sciences, Penn State College of Medicine, Hershey, PA, USA; Department of Humanities, Penn State College of Medicine, Hershey, PA, USA.

Förderung

  • NCI NIH HHS
  • NCATS NIH HHS
  • National Cancer Institute
  • National Center for Advancing Translational Sciences

Zitieren

APA

Calo, W. A., Shah, P. D., Fogel, B. N., Ruffin Iv, M. T., Moss, J. L., Hausman, B. L., Segel, J. E., Francis, E., Schaefer, E., Bufalini, C. M., Johnston, N., Hogentogler, E., & Kraschnewski, J. L. (2023). Increasing the adoption of evidence-based communication practices for HPV vaccination in primary care clinics: The HPV ECHO study protocol for a cluster randomized controlled trial. Contemporary Clinical Trials. https://doi.org/10.1016/j.cct.2023.107266

Vancouver

Calo WA, Shah PD, Fogel BN, Ruffin Iv MT, Moss JL, Hausman BL, et al. Increasing the adoption of evidence-based communication practices for HPV vaccination in primary care clinics: The HPV ECHO study protocol for a cluster randomized controlled trial. Contemporary Clinical Trials. 2023. doi:10.1016/j.cct.2023.107266

BibTeX
@article{Calo2023,
  author = {Calo, William A and Shah, Parth D and Fogel, Benjamin N and Ruffin Iv, Mack T and Moss, Jennifer L and Hausman, Bernice L and Segel, Joel E and Francis, Erica and Schaefer, Eric and Bufalini, Chelsea M and Johnston, Nikole and Hogentogler, Ellie and Kraschnewski, Jennifer L},
  title = {Increasing the adoption of evidence-based communication practices for HPV vaccination in primary care clinics: The HPV ECHO study protocol for a cluster randomized controlled trial},
  journal = {Contemporary Clinical Trials},
  year = {2023},
  doi = {10.1016/j.cct.2023.107266}
}
Kostenlos starten →